GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Cyclically Adjusted Price-to-FCF

Nanjing Vishee Medical Technology Co (SHSE:688580) Cyclically Adjusted Price-to-FCF : 43.35 (As of Jun. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-20), Nanjing Vishee Medical Technology Co's current share price is ¥28.18. Nanjing Vishee Medical Technology Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was ¥0.65. Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF for today is 43.35.

The historical rank and industry rank for Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:688580' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 43.04   Med: 57.03   Max: 65.79
Current: 43.04

During the past 10 years, Nanjing Vishee Medical Technology Co's highest Cyclically Adjusted Price-to-FCF was 65.79. The lowest was 43.04. And the median was 57.03.

SHSE:688580's Cyclically Adjusted Price-to-FCF is ranked worse than
52.97% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 41.72 vs SHSE:688580: 43.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Nanjing Vishee Medical Technology Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was ¥0.007. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.65 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanjing Vishee Medical Technology Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Cyclically Adjusted Price-to-FCF Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 69.84

Nanjing Vishee Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 69.84 -

Competitive Comparison of Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF falls into.



Nanjing Vishee Medical Technology Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=28.18/0.65
=43.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Vishee Medical Technology Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Nanjing Vishee Medical Technology Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.007/114.7809*114.7809
=0.007

Current CPI (Dec23) = 114.7809.

Nanjing Vishee Medical Technology Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201612 0.195 102.600 0.218
201712 0.532 104.500 0.584
201812 0.626 106.500 0.675
201912 1.676 111.200 1.730
202012 1.335 111.500 1.374
202112 0.730 113.108 0.741
202212 -0.099 115.116 -0.099
202312 0.007 114.781 0.007

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanjing Vishee Medical Technology Co  (SHSE:688580) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Nanjing Vishee Medical Technology Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Executives
Huang He Senior management, core technical personnel
Chou Kai Senior management, core technical personnel
Zhong Yi Qun senior management
Chen Li Li Directors, senior managers
Zhang Hui senior management
Gao Fei Core technical personnel
Lian Qing Ming Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines